These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

674 related articles for article (PubMed ID: 31217745)

  • 1. Immunohistochemistry of YAP and dNp63 and survival analysis of patients bearing precancerous lesion and oral squamous cell carcinoma.
    Ono S; Nakano K; Takabatake K; Kawai H; Nagatsuka H
    Int J Med Sci; 2019; 16(5):766-773. PubMed ID: 31217745
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased ΔNp63 expression is predictive of malignant transformation in oral epithelial dysplasia and poor prognosis in oral squamous cell carcinoma.
    Matsubara R; Kawano S; Kiyosue T; Goto Y; Hirano M; Jinno T; Toyoshima T; Kitamura R; Oobu K; Nakamura S
    Int J Oncol; 2011 Dec; 39(6):1391-9. PubMed ID: 21833468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KRT84 is a potential tumor suppressor and good prognosis signature of oral squamous cell carcinoma.
    Liu Y; Li R; Ren G
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32181476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ki-67 Prognostic Value in Different Histological Grades of Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
    Takkem A; Barakat C; Zakaraia S; Zaid K; Najmeh J; Ayoub M; Seirawan MY
    Asian Pac J Cancer Prev; 2018 Nov; 19(11):3279-3286. PubMed ID: 30486632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Joint detection of claudin-1 and junctional adhesion molecule-A as a therapeutic target in oral epithelial dysplasia and oral squamous cell carcinoma.
    Upadhaya P; Barhoi D; Giri A; Bhattacharjee A; Giri S
    J Cell Biochem; 2019 Oct; 120(10):18117-18127. PubMed ID: 31161679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stathmin! An immunohistochemical analysis of the novel marker in Oral Squamous Cell Carcinoma and Oral Leukoplakia.
    Vadla P; Yeluri S; Deepthi G; Guttikonda VR; Taneeru S; Naramala S
    Asian Pac J Cancer Prev; 2020 Nov; 21(11):3317-3323. PubMed ID: 33247690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subcellular differential expression of Ep-ICD in oral dysplasia and cancer is associated with disease progression and prognosis.
    Somasundaram RT; Kaur J; Leong I; MacMillan C; Witterick IJ; Walfish PG; Ralhan R
    BMC Cancer; 2016 Jul; 16():486. PubMed ID: 27421772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant Kank1 expression regulates YAP to promote apoptosis and inhibit proliferation in OSCC.
    Fan H; Tian H; Cheng X; Chen Y; Liang S; Zhang Z; Liao Y; Xu P
    J Cell Physiol; 2020 Feb; 235(2):1850-1865. PubMed ID: 31338836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interplay between ΔNp63 and miR-138-5p regulates growth, metastasis and stemness of oral squamous cell carcinoma.
    Zhuang Z; Xie N; Hu J; Yu P; Wang C; Hu X; Han X; Hou J; Huang H; Liu X
    Oncotarget; 2017 Mar; 8(13):21954-21973. PubMed ID: 28423539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant expression of β-catenin and its association with ΔNp63, Notch-1, and clinicopathological factors in oral squamous cell carcinoma.
    Ravindran G; Devaraj H
    Clin Oral Investig; 2012 Aug; 16(4):1275-88. PubMed ID: 21881870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of MCM5 is significantly associated with aggressive progression and poor prognosis of oral squamous cell carcinoma.
    Yu SY; Wang YP; Chang JY; Shen WR; Chen HM; Chiang CP
    J Oral Pathol Med; 2014 May; 43(5):344-9. PubMed ID: 24245508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of JAG2 is related to poor outcomes in oral squamous cell carcinoma.
    Hatano K; Saigo C; Kito Y; Shibata T; Takeuchi T
    Clin Exp Dent Res; 2020 Apr; 6(2):174-180. PubMed ID: 32250571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Gα12 predicts progression and prognosis of oral squamous cell carcinomas in Taiwan.
    Cheng SJ; Liu YC; Cheng SL; Lee JJ; Chen HM; Chang HH; Kok SH; Kuo MY; Chiang CP
    J Oral Pathol Med; 2013 Aug; 42(7):565-9. PubMed ID: 23438080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of DLC1 is an independent prognostic factor in patients with oral squamous cell carcinoma.
    Tripathi SC; Kaur J; Matta A; Gao X; Sun B; Chauhan SS; Thakar A; Shukla NK; Duggal R; Choudhary AR; DattaGupta S; Sharma MC; Ralhan R; Siu KW
    Mod Pathol; 2012 Jan; 25(1):14-25. PubMed ID: 22002576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. YAP signaling induces PIEZO1 to promote oral squamous cell carcinoma cell proliferation.
    Hasegawa K; Fujii S; Matsumoto S; Tajiri Y; Kikuchi A; Kiyoshima T
    J Pathol; 2021 Jan; 253(1):80-93. PubMed ID: 32985688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical Evaluation of GLUT-3 and GLUT-4 in Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
    Feitosa SG; Viana KF; Luna ECM; Costa FWG; Cavalcante RB; Chaves FN; Chaves HV; Pereira KMA
    Asian Pac J Cancer Prev; 2018 Jul; 19(7):1779-1783. PubMed ID: 30049187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of Kif5b protein is significantly associated with the progression, recurrence and prognosis of oral squamous cell carcinoma.
    Luan YJ; Xu Y; Cai J; Dou Y; Yu WJ; Wang KT; Liu SH; Yang PS; Qu X; Wei FC
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4542-4550. PubMed ID: 30058692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue mechanics and expression of TROP2 in oral squamous cell carcinoma with varying differentiation.
    Zhang B; Gao S; Li R; Li Y; Cao R; Cheng J; Guo Y; Wang E; Huang Y; Zhang K
    BMC Cancer; 2020 Aug; 20(1):815. PubMed ID: 32854652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PI3K-AKT-mTOR pathway proteins are differently expressed in oral carcinogenesis.
    Martins F; de Sousa SC; Dos Santos E; Woo SB; Gallottini M
    J Oral Pathol Med; 2016 Nov; 45(10):746-752. PubMed ID: 26991907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene Expression Clustering and Selected Head and Neck Cancer Gene Signatures Highlight Risk Probability Differences in Oral Premalignant Lesions.
    Carenzo A; Serafini MS; Roca E; Paderno A; Mattavelli D; Romani C; Saintigny P; Koljenović S; Licitra L; De Cecco L; Bossi P
    Cells; 2020 Aug; 9(8):. PubMed ID: 32756466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.